Your Molecule

Locate the ideal DAISOGEL bulk silica product for your application by selecting the type of molecule that you wish to purify

A range of phases with unique carbon loading, chemical resistances, pore sizes and selectivities are available for different molecules.

Small Molecules

Small Molecules

Chemical entities such as paclitaxel, beta blockers, and statins are chemically synthesized and have a molecular weight of less than 2 kD – hence the term “small molecule.” We offer many silica gels for small molecule purification.

Learn More
Cannabinoids

Cannabinoids

With the growth of medicinal and recreational cannabis markets, interest in single cannabinoids have become increasingly important in pharmaceuticals as CBD’s therapeutic properties and recent research have proven useful in fighting a variety of health conditions.

Learn More
Fish Oil (EPA)

Fish Oil (EPA)

Fish oil helps the brain in treating mild memory loss and depression. Our DAISOGEL ODS-BP in 120 Å is designed to show extended selectivity for hydrophilic and polar compounds due to its enhanced endcapping.

Learn More
Synthetic Peptides

Synthetic Peptides

As their name implies, synthetic peptides are chemically synthesized on a solid phase using Fmoc or Boc chemistry. DAISOGEL offers many silica gel products suitable for synthetic peptide purifications.

Learn More
Recombinant Peptides / Insulin

Recombinant Peptides / Insulin

Recombinant peptides are typically produced from microbial expression systems such as bacteria or yeast. DAISOGEL offers silica gels that are ideal for purifying these challenging molecules.

Learn More
Recombinant Proteins / EPO

Recombinant Proteins / EPO

Our C4-P series is bonded with butyl groups to show moderate hydrophobicity and best suited for the purification of Erythropoietin and other blood cell stimulating factors.

Learn More

“A big thanks to DAISO Fine Chem on all of the support from beginning to end. All of the technical support provided from your R&D team was a big benefactor to our success!”

Senior Director MSAT, Insulin Business Unit